Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer.
Porcaro AB, Tafuri A, Panunzio A, Rizzetto R, Amigoni N, Cerrato C, Shakir A, Gallina S, Bianchi A, Cianflone F, Serafin E, Gozzo A, Di Filippo G, Migliorini F, Novella G, Brunelli M, Cerruto MA, Antonelli A.
Porcaro AB, et al. Among authors: panunzio a.
Int Urol Nephrol. 2021 Dec;53(12):2517-2526. doi: 10.1007/s11255-021-02990-9. Epub 2021 Sep 27.
Int Urol Nephrol. 2021.
PMID: 34580803
Free PMC article.